Haran Sivakumaran

Brisbane, QLD 4029, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 33 publications

BRRIAR lncRNA alters breast cancer risk by modulating interferon signaling in cis and in trans.

BRRIAR lncRNA alters breast cancer risk by modulating interferon signaling in cis and in trans.

Journal: Molecular cancer
Published: July 08, 2025

GWAS and 3D chromatin mapping identifies multicancer risk genes associated with hormone-dependent cancers.

GWAS and 3D chromatin mapping identifies multicancer risk genes associated with hormone-dependent cancers.

Journal: PLoS genetics
Published: July 10, 2024

CRISPR-Cas13d screens identify KILR, a breast cancer risk-associated lncRNA that regulates DNA replication and repair.

CRISPR-Cas13d screens identify KILR, a breast cancer risk-associated lncRNA that regulates DNA replication and repair.

Journal: Molecular cancer
Published: November 17, 2023

Regulation of non-canonical proteins from diverse origins through the nonsense-mediated mRNA decay pathway.

Regulation of non-canonical proteins from diverse origins through the nonsense-mediated mRNA decay pathway.

Journal: Proteomics
Published: September 18, 2023

Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179.

Preventing recurrence in Sonic Hedgehog Subgroup Medulloblastoma using the OLIG2 inhibitor CT-179.

Journal: Research square
Published: June 19, 2023

Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179.

Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179.

Journal: Nature communications
Published: May 17, 2023

Lentiviral Transduction-based CRISPR/Cas9 Editing of Schistosoma mansoni Acetylcholinesterase.

Lentiviral Transduction-based CRISPR/Cas9 Editing of Schistosoma mansoni Acetylcholinesterase.

Journal: Current genomics
Published: March 16, 2023

Development of CRISPR/Cas13a-based assays for the diagnosis of Schistosomiasis.

Development of CRISPR/Cas13a-based assays for the diagnosis of Schistosomiasis.

Journal: EBioMedicine
Published: March 11, 2023

CRISPR interference for sequence-specific regulation of fibroblast growth factor receptor A in Schistosoma mansoni.

CRISPR interference for sequence-specific regulation of fibroblast growth factor receptor A in Schistosoma mansoni.

Journal: Frontiers in immunology
Published: November 23, 2022

CRISPR screens identify gene targets at breast cancer risk loci.

CRISPR screens identify gene targets at breast cancer risk loci.

Journal: Genome biology
Published: September 18, 2022

eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene.

eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene.

Journal: American journal of human genetics
Published: April 29, 2020

Chromatin interactome mapping at 139 independent breast cancer risk signals.

Chromatin interactome mapping at 139 independent breast cancer risk signals.

Journal: Genome biology
Published: March 11, 2019
Showing 1-12 of 33

Last Updated: 09/26/2026